The heart in Anderson-Fabry disease and other lysosomal storage disorders
- PMID: 17401074
- PMCID: PMC1861503
- DOI: 10.1136/hrt.2005.063818
The heart in Anderson-Fabry disease and other lysosomal storage disorders
Conflict of interest statement
In compliance with EBAC/EACCME guidelines, all authors participating in Education in
Similar articles
-
A wild zebra chase.Nephrol Dial Transplant. 2007 Oct;22(10):3074-7. doi: 10.1093/ndt/gfm462. Epub 2007 Jul 10. Nephrol Dial Transplant. 2007. PMID: 17623715 No abstract available.
-
Anderson-Fabry disease and other lysosomal storage disorders.Circulation. 2014 Sep 23;130(13):1081-90. doi: 10.1161/CIRCULATIONAHA.114.009789. Circulation. 2014. PMID: 25245844 Review. No abstract available.
-
Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.Clin Respir J. 2020 May;14(5):422-429. doi: 10.1111/crj.13150. Epub 2020 Jan 22. Clin Respir J. 2020. PMID: 31912638 Review.
-
Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice.Mo Med. 2004 Mar-Apr;101(2):100-4. Mo Med. 2004. PMID: 15119106 Review.
-
Enzyme replacement and enhancement therapies: lessons from lysosomal disorders.Nat Rev Genet. 2002 Dec;3(12):954-66. doi: 10.1038/nrg963. Nat Rev Genet. 2002. PMID: 12459725 Review.
Cited by
-
Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis, Prognosis, and Treatment of Infiltrative Cardiomyopathies.Curr Cardiol Rep. 2021 Jun 3;23(7):87. doi: 10.1007/s11886-021-01518-y. Curr Cardiol Rep. 2021. PMID: 34081227 Review.
-
Anderson-Fabry Disease: Red Flags for Early Diagnosis of Cardiac Involvement.Diagnostics (Basel). 2024 Jan 18;14(2):208. doi: 10.3390/diagnostics14020208. Diagnostics (Basel). 2024. PMID: 38248084 Free PMC article. Review.
-
Metabolic Disorders and Anesthesia.Curr Anesthesiol Rep. 2019 Sep;9(3):340-359. doi: 10.1007/s40140-019-00345-w. Epub 2019 Jul 12. Curr Anesthesiol Rep. 2019. PMID: 31406490 Free PMC article.
-
Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives.J Clin Med. 2023 Sep 1;12(17):5710. doi: 10.3390/jcm12175710. J Clin Med. 2023. PMID: 37685777 Free PMC article. Review.
-
Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review.J Cardiovasc Ultrasound. 2016 Dec;24(4):257-267. doi: 10.4250/jcu.2016.24.4.257. Epub 2016 Dec 28. J Cardiovasc Ultrasound. 2016. PMID: 28090249 Free PMC article. Review.
References
-
- Mehta A, Ricci R, Widmer U.et al Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 200434236–242.Analysis of the largest ever published dataset of Anderson‐Fabry disease patients. Comprehensive overview of disease key manifestations, prevalence and significance. - PubMed
-
- Sachdev B, Takenaka T, Teraguchi H.et al Prevalence of Anderson‐Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 20021051407–1411.Key study indicating larger prevalence of Anderson‐Fabry disease among patients with late onset hypertrophic cardiomyopathy. - PubMed